St. Louis (April 3, 2003) - Divergence, Inc. was a presenting company at the BIO Mid-America Venture Forum in Chicago, Illinois today, the first BIO venture forum in the U.S. mid-west. BIO is the Biotechnology Industry Organization.

"This conference provides a great opportunity for Divergence to update the investment community on our rapid progress," said Derek Rapp, Chief Executive Officer of Divergence and forum presenter. "We appreciate the recognition as a company with significant science targeting large, promising markets."

"Divergence is also proud to be among the St. Louis-based companies representing Missouri's Biobelt at this regional forum," continued Rapp. "Interactions with local organizations including Washington University and the Danforth Plant Science Center in St. Louis have been key to the success of Divergence, as have been relationships with investors in both Chicago and St. Louis. We are encouraged by the growing presence of biotechnology companies in St. Louis and the focus of BIO on the Mid-America region."

Divergence is a research and development company dedicated to the discovery of effective and ecologically sound strategies for the control of parasites and other pests. The company's initial focus is on parasitic nematodes, one of the world's major pest groups. Nematodes are roundworms that cause billions of dollars in damage annually to numerous crops, including soybeans, corn, and cotton, as well as most fruits and vegetables. Nematodes also cause widespread disease in animals, including infections such as heartworm in dogs and cats and intestinal worms in livestock. Nematode-induced human diseases include elephantiasis and African river blindness.

Visit St. Louis Commerce Magazine April 2003 coverage.

For more information on Divergence, visit www.divergence.com.